Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), the most severe form of drug hypersensitivity response with a 50% fatality rate, are often linked to antiepileptic medications (AEDs). Nevertheless, there hasn't been a thorough analysis of the total percentage of these instances linked to AEDs. Thus, the purpose of this study was to assess the percentage of AED-associated SJS/TEN.
From the beginning until March 17, 2026, the MEDLINE and Embase databases were searched; only English-language papers and human subjects were included in the findings. Included were all observational and experimental studies that documented SJS/TEN triggers at the patient level. Using a predetermined template, two reviewers independently reviewed studies and retrieved data. A random-effects meta-analysis was used to calculate the pooled proportions with 95% CIs in order to assess the proportion of AED-associated SJS/TEN. To investigate heterogeneity, subgroup analyses by age group (children vs. adults) and geographic area were carried out.
50 studies with 4403 patients that identified SJS/TEN triggers at the patient level were included in this systematic review and meta-analysis. 88% (95% CI, 83-92) of the instances had single-drug triggers.
AEDs were responsible for 23% (95% CI, 19–26) of the total number of SJS/TEN cases. Aromatic AEDs accounted for nearly all AED-associated cases (96%; 95% CI, 92-99), most often carbamazepine (39%; 95% CI, 29-50), phenytoin (19%; 95% CI, 11-28), and lamotrigine (15%; 95% CI, 8-22). Rarely were nonaromatic AEDs involved (2%; 95% CI, 0-4).
The percentage of AED-associated SJS/TEN varied significantly by region, from 42% (95% CI, 26-59) in West Asia to 10% (95% CI, 0-33) in Africa. Compared to adults, children had a much greater percentage of AED-associated SJS/TEN cases.
Overall, roughly 25% of SJS/TEN cases reported globally were linked to AEDs. Carbamazepine, phenytoin, and lamotrigine were the most often implicated aromatic compounds in nearly all AED-associated cases. These results support the preferential use of nonaromatic AEDs, particularly in high-risk patients and when clinically appropriate, and point to aromatic AEDs as the primary causes of SJS/TEN.
Source:
Lee, E. Y., Knox, C., Sugumar, C., & Phillips, E. J. (2026). Proportion of antiepileptic drug-associated Stevens-Johnson syndrome and toxic epidermal necrolysis: A meta-analysis: A meta-analysis. JAMA Dermatology (Chicago, Ill.). https://doi.org/10.1001/jamadermatol.2026.2473
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.